CCL19 and systemic sclerosis: However, mRNA levels of CCL19 and CCL21, the ligands of CCR7, were not significantly different in lungs of patients with idiopathic PAH as compared to controls [48], although CCL19 is thought to be a sensitive marker for perivascular inflammation in systemic sclerosis.